Dilantin Linked to Osteoporosis
A recent study revealed that the popular epilepsy drug Dilantin might be placing young women who take it for a year or more at higher risk for osteoporosis. The April 29 issue of Neurology states the bone loss described in the research was actually eight times higher than that experienced by pre-menopausal women not taking […]
More: continued here